Table 1 Baseline characteristics of the four treatment modality groups
| Â | Â | Total n = 154 (100%) | Surgery Only n = 34 (22%) | Surgery+CT n = 40 (26%) | Surgery+CRT n = 40 (26%) | CRT+Surgery+CT n = 40 (26%) | P Value |
|---|---|---|---|---|---|---|---|
Gender (%) | Male | 88 (57.1) | 18 (11.7) | 24 (15.6) | 21 (13.6) | 25 (16.2) | 0.753 |
| Â | Female | 66 (42.9) | 16 (10.3) | 16 (10.4) | 19 (12.4) | 15 (9.8) | Â |
Mean time to assessment, months (SD)* | 10.4 (2.9) | 9.8 (2.5) | 9.6 (2.2) | 9.7 (2.5) | 9.7 (2.2) | 0.879 | |
Median age (range) | 57 (30-70) | 54 (26-70) | 52.5 (27-68) | 52 (26-70) | 55.5 (39-69) | 0.004 | |
Mean distance from anal verge, cm (range, SD) | 6.9 (2-12, 2.9) | 6.2 (1-12, 2.9) | 7.0 (1-12, 2.7) | 5.9 (1-12, 3.2) | 4.8 (1-12, 2.2) | 0.002 | |
Postoperative pTNM stage (%) | Stage I | 37 (24) | 28 (18.2) | 3 (1.9) | 0 | 6 (3.9) | <0.001 |
| Â | Stage II | 44 (28.6) | 6 (3.1) | 18 (11.7) | 11 (7.1) | 9 (5.8) | Â |
| Â | Stage III | 73 (47.4) | 0 | 19 (12.4) | 29 (18.9) | 25 (16.3) | Â |
Stoma (%) | Yes | 75 (48.7) | 14 (9.1) | 14 (9.1) | 22 (14.3) | 25 (16.2) | 0.06 |
| Â | No | 79 (51.3) | 20 (12.9) | 26 (16.9) | 18 (11.7) | 15 (9.8) | Â |